Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure.
about
Contemporary Approaches to Modulating the Nitric Oxide-cGMP Pathway in Cardiovascular Disease.The Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics.Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding.Prevention of PKG-1α Oxidation Suppresses Antihypertrophic/Antifibrotic Effects From PDE5 Inhibition but not sGC Stimulation.
P2860
Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure.
@en
Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure.
@nl
type
label
Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure.
@en
Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure.
@nl
prefLabel
Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure.
@en
Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure.
@nl
P2093
P2860
P356
P1476
Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure.
@en
P2093
Kelly S Lewis
Lothar Roessig
Peter Sandner
Stefanie Breitenstein
P2860
P304
P356
10.1007/164_2016_100
P577
2016-11-30T00:00:00Z